About:
Posts by :
-
June 2, 2013 Akt inhibition for cancer treatment, where do we stand today?
-
June 1, 2013 FDA approved two drugs and a companion diagnostic test for the treatment of advanced or unresectable cutaneous melanoma patients
-
May 22, 2013 Soft Tissue Sarcoma: an Overview
-
May 9, 2013 The Development of siRNA-Based Therapies for Cancer
-
April 23, 2013 Whole exome somatic mutations analysis of malignant melanoma contributes to the development of personalized cancer therapy for this disease
-
April 6, 2013 Targeting Mitochondrial-bound Hexokinase for Cancer Therapy
-
March 25, 2013 Cancer Screening at Sourasky Medical Center Cancer Prevention Center in Tel-Aviv
-
March 16, 2013 A P(hD)aradox
-
March 7, 2013 The Importance of Cancer Prevention Programs: New Percpectives for Fighting Cancer
-
Recent Posts
- Two Site Map Proposals for LPBI’s New Web Site December 2, 2020
- COVID-19 T-cell immune response map, immunoSEQ T-MAP COVID for research of T-cell response to SARS-CoV-2 infection November 20, 2020
- Nanoparticles can turn off genes in bone marrow cells November 19, 2020
- The complication of Pfizer’s Vaccine Distribution’s Plan November 19, 2020
- Regeneron’s new antibody cocktail drug, REGN-COV2 November 18, 2020
- McKinsey experts on COVID-19: Implications for business: Executive Briefing November 18, 2020
- Leveraging Clinical Narrative Text at Scale: Applying Natural Language Processing to Understand the Patient Care Experience @NIH.gov November 18, 2020
- re:Invent 2020 – Virtual 3 weeks Conference, Nov. 30 – Dec. 18, 2020: How Healthcare & Life Sciences leaders are using AWS to transform their businesses and innovate on behalf of their customers. November 18, 2020
- Data Architecture for Blockchain Deployment of Digital Assets: LPBI IP Asset Classes I,II,III November 16, 2020
- First-ever living 3D-printed aneurysm November 15, 2020
Archives
Categories
Meta
